Investigative Site

Valencia 46009

0 studies enrolling now · 2 studies all time

What they study most

Essential Hypertension, Pancreatic Cancer

Studies at this site

• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients — Completed
• Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension. — Completed